superior to chemotherapy alone, but e.g. cetuximab have been shown to revert chemoresistance. More phase II data preferably from randomized trials is needed in order to select the most promising
time (ii) the lack of support for obstacles in the spatial data space. (iii) Compare computation time of HARP, Proclus, Doc, FastDoc, SSPC algorithms. Approach: During the first phase
aqueous solutions. Physical, chemical and liquid-phase adsorption characterizations of the Resin was done following standard procedures. Studies on the removal of Ni(II) ion was attempted by varying
view of: (i) The effect of IFN? on non-transformed cell line and (ii) The side effect of interferon therapy on normal cells in cancer patients. Using the non-transformed ... prior to the activation step of cyclin…
Purpose: The purpose of this prospective phase III study was to compare the role of concomitant chemoradiation using paclitaxel versus cisplatin in locally advanced head and neck cancers. Patients ... concomitant…
studied at T=298.2 K under atmospheric pressure. Effect of initial Cu(II) concentration in aqueous phase ... function of organic phase composition, acid concentration, aqueous pH, primary copper concentration. The…
HDIs and DNMT inhibitors available nowadays has led to promising results in Phase I, II and III clinical oncology studies. While it was first believed that these molecules would
precise and reproducible HPLC and HPTLC methods for the analysis of Pravastatin (I), Simvastatin (II) and Ezetimibe (III) at ambient temperature. (I) was determined in presence of its acid, alkaline ... chloroform(9:1…
when combined with gemcitabine. The survival benefits will be tested in the following randomized phase II trial. The new combination of gemcitabine and blockade of checkpoint kinases with AZD7762 showed ... cancer. The…
progression-free survival compared to placebo. Novel agents were also presented, including a phase II trial looking at the combination of sorafenib and bevacizumab (Abstract #4113), and a phase
clear that some form of adjuvant therapy should be considered in these patients. A phase II study was presented at the 2011 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers
anti-herpetic treatment have all proven to be safe in pancreatic cancer patients. Phase II trials will provide further evidence whether they can become clinically relevant in the future
contest, the present work is carried out which includes Uncontrolled randomized, open labelled, multicentric Phase III clinical trial using oral Ayurvedic multicomponent preparations with or without use of Ayurvedic…
associated with environmental pollution. The biomarkers selected were the antioxidant enzymes catalase (CAT), the phase II detoxifying enzyme glutathione S transferase (GST) and the neurotoxicity marker…
quite effective against TB. A very promising TB vaccine, MVA85A, is currently in phase II trials and is based on a genetically modified vaccinia virus. Many other strategies are also
II – VI semiconductor nanocrystals are recently developed class of nanomaterials whose unique photophysical properties are helping to create a new generation in the field of photonics and microelectronics. In this…
navigation behaviour. The proposed system works in two phases, (i) the offline phase and (ii) the online phase. The offline phase takes care of preprocessing and clustering, while the classification
type-II Diabetes mellitus is altered when concomitantly administered with other drugs like, antacids, antinuclear drugs, antibiotics and others. A randomized cross over study with two phases and a washout
glutathione S-transferase (GST) family consists of phase II detoxification enzymes that catalyze the conjugation of toxic substances, such as chemotherapeutic agents, to glutathione. We examined whether GSTT1/GSTT1“null
develop COPD. It belongs to the GST family, which is a group of phase II enzymes that catalyze the glutathione conjugation of many endogenous and exogenous electrophilic compounds, such
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.